CAPILLARY TECHNOLOGIES EUROPE LIMITED

Company Registration Number:
03297240 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2026

Period of accounts

Start date: 01 April 2025

End date: 31 March 2026

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2026

Balance sheet
Notes

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Balance sheet

As at 31 March 2026


Notes
2026
2025


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 5,255 10,809
Investments:   0 0
Total fixed assets: 5,255 10,809
Current assets
Stocks: 0 0
Debtors: 4 2,609,778 2,065,702
Cash at bank and in hand: 1,821,066 395,105
Investments:   0 0
Total current assets: 4,430,844 2,460,807
Creditors: amounts falling due within one year: 5 (3,318,313) (1,626,524)
Net current assets (liabilities): 1,112,531 834,283
Total assets less current liabilities: 1,117,786 845,092
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 1,117,786 845,092
Capital and reserves
Called up share capital: 389,409 389,409
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 161,189 118,369
Profit and loss account: 567,188 337,314
Shareholders funds: 1,117,786 845,092

The notes form part of these financial statements

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 04 May 2026
and signed on behalf of the board by:

Name: Anant Choubey
Status: Director

The notes form part of these financial statements

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

2. Employees

2026 2025
Average number of employees during the period 8 13

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

3. Tangible Assets

Total
Cost £
At 01 April 2025 50,038
Additions 0
Disposals (10,943)
Revaluations 0
Transfers 0
At 31 March 2026 39,095
Depreciation
At 01 April 2025 39,229
Charge for year 4,923
On disposals (10,312)
Other adjustments 0
At 31 March 2026 33,840
Net book value
At 31 March 2026 5,255
At 31 March 2025 10,809

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

4. Debtors

2026 2025
££
Debtors due after more than one year: 0 0

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

5. Creditors: amounts falling due within one year note

FOR FINANCIAL YEAR 2025-26 CREDITORS FALLING DUE WITHIN ONE YEAR = 3,318,313 FOR FINANCIAL YEAR 2024-25 CREDITORS FALLING DUE WITHIN ONE YEAR = 1,626,524.